JP2022542294A5 - - Google Patents

Info

Publication number
JP2022542294A5
JP2022542294A5 JP2022505585A JP2022505585A JP2022542294A5 JP 2022542294 A5 JP2022542294 A5 JP 2022542294A5 JP 2022505585 A JP2022505585 A JP 2022505585A JP 2022505585 A JP2022505585 A JP 2022505585A JP 2022542294 A5 JP2022542294 A5 JP 2022542294A5
Authority
JP
Japan
Prior art keywords
protein
functional fragment
seq
modified
mycoplasma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022505585A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022542294A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/044559 external-priority patent/WO2021022187A1/en
Publication of JP2022542294A publication Critical patent/JP2022542294A/ja
Publication of JP2022542294A5 publication Critical patent/JP2022542294A5/ja
Priority to JP2025139669A priority Critical patent/JP2026000908A/ja
Pending legal-status Critical Current

Links

JP2022505585A 2019-08-01 2020-07-31 抗体に結合して中和抗体を阻害するための組成物および方法 Pending JP2022542294A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025139669A JP2026000908A (ja) 2019-08-01 2025-08-25 抗体に結合して中和抗体を阻害するための組成物および方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962881765P 2019-08-01 2019-08-01
US62/881,765 2019-08-01
PCT/US2020/044559 WO2021022187A1 (en) 2019-08-01 2020-07-31 Compositions and methods for binding antibodies and inhibiting neutralizing antibodies

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025139669A Division JP2026000908A (ja) 2019-08-01 2025-08-25 抗体に結合して中和抗体を阻害するための組成物および方法

Publications (2)

Publication Number Publication Date
JP2022542294A JP2022542294A (ja) 2022-09-30
JP2022542294A5 true JP2022542294A5 (https=) 2023-08-01

Family

ID=74230547

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022505585A Pending JP2022542294A (ja) 2019-08-01 2020-07-31 抗体に結合して中和抗体を阻害するための組成物および方法
JP2025139669A Pending JP2026000908A (ja) 2019-08-01 2025-08-25 抗体に結合して中和抗体を阻害するための組成物および方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025139669A Pending JP2026000908A (ja) 2019-08-01 2025-08-25 抗体に結合して中和抗体を阻害するための組成物および方法

Country Status (10)

Country Link
US (1) US20220260563A1 (https=)
EP (1) EP4007768A4 (https=)
JP (2) JP2022542294A (https=)
KR (1) KR20220053575A (https=)
CN (1) CN114514239A (https=)
AU (1) AU2020319880A1 (https=)
CA (1) CA3149679A1 (https=)
IL (1) IL290219A (https=)
MX (1) MX2022001425A (https=)
WO (1) WO2021022187A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4288445A1 (en) * 2021-02-03 2023-12-13 The University of North Carolina at Chapel Hill Protein m analogs and fusion proteins and their use for inhibiting antibody function
CN116376942A (zh) * 2021-12-31 2023-07-04 广州国家实验室 mRNA疫苗
CN115047188A (zh) * 2022-06-10 2022-09-13 上海鼎新基因科技有限公司 一种抗腺相关病毒中和抗体的检测方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5804183A (en) * 1997-01-31 1998-09-08 Enzon, Inc. Arginine deminase derived from mycoplasma arthritidis and polymer conjugates containing the same
HK1202434A1 (en) * 2011-11-22 2015-10-02 The Children's Hospital Of Philadelphia Virus vectors for highly efficient transgene delivery
AU2013204555A1 (en) * 2012-04-30 2013-11-14 Oncolytics Biotech Inc. Protecting modified viruses from neutralizing antibodies using the reovirus sigma 1 protein
US9593150B2 (en) * 2012-07-16 2017-03-14 The Scripps Research Institute Immunoglobulin-binding human mycoplasma antigens and methods of use thereof
WO2015117057A2 (en) * 2014-01-31 2015-08-06 The Scripps Research Institute Protein m related immunoglobulin-binding polypeptides
EP3204503A1 (en) * 2014-10-06 2017-08-16 Arthrogen BV Aav-based gene therapy
SG11201803098VA (en) * 2015-10-30 2018-05-30 Nbe Therapeutics Ag Anti-ror1 antibodies
DE102016123859B3 (de) * 2016-12-08 2018-03-01 Immatics Biotechnologies Gmbh Neue T-Zellrezeptoren und deren Verwendung in Immuntherapie

Similar Documents

Publication Publication Date Title
US7968512B2 (en) Conjugates that contain the homeodomain of antennapedia
JP2022542294A5 (https=)
AU2001292619A1 (en) Novel compounds
WO2002022802A1 (en) Novel compounds
JP2004500100A (ja) 新規化合物
CN118221829A (zh) 一种il-10单体融合蛋白
CN110845596B (zh) 突变体xSUMO及其相关产品
CN102766202B (zh) Phf14 c端蛋白、其多克隆抗体及应用
CN106317225A (zh) 具有靶向性长效白细胞介素22融合蛋白及其制备方法和用途
JPH11507825A (ja) Ｄｎアーゼ活性を有する蛋白質
JP2000506733A (ja) チロシンホスファターゼ関連タンパク質
JP2002514417A (ja) Ｒｈｏの推定上の標的であるロテキン
JPH11510382A (ja) トランスケトラーゼ関連蛋白質
EP1274842A2 (en) Lipid binding protein 4
CN1318448C (zh) 一种重组全长人脑红素、其生产方法及其应用
JP2008500006A (ja) ペプチド複合体
CN1148381C (zh) 新的人趋化因子巨噬细胞炎性蛋白、其编码序列及用途
JP2003523748A (ja) 新規ホスホジエステラーゼ７ｂ型
US20050107592A1 (en) Lipid binding protein 1
CA3148273A1 (en) Compositions and methods utilizing a novel human foxo3 isoform
WO2001079492A2 (en) Lipid binding protein 3
McAfee Genetic and DNA binding studies on a 7 kDa protein from Sulfolobus acidocaldarius.
WO2001030818A1 (fr) Nouveau polypeptide, proteine de liaison 33 a l'arn, et polynucleotide codant pour ce polypeptide
JP2000500962A (ja) Ｆｍｒ１関連蛋白質
WO2001079493A1 (en) New lipid binding protein 2